Spartalizumab
Spartalizumab (PDR001) is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to PD-1 at low concentrations, exhibiting high activity. It blocks the interaction with PD-L1 and PD-L2, making it suitable for studying undifferentiated thyroid cancer (ATC) .
Product Specifications
CAS Number
1935694-88-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
PD-1/PD-L1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx107204-01 20 µg
ATPase, H+/K+ Exchanging Beta Polypeptide (ATP4B) Antibody (FITC)
Ask
View Details